Exchange: NASDAQ·Updated 07:49 PM EDT

ALGN News

News
all
press releases
Should You Continue to Hold ALGN Stock in Your Portfolio?
Align Technology expands Invisalign and digital dentistry adoption as iTero gains traction, but weak capital spending and currency volatility remain risks.
Zacks
More News
Align Technology to Speak at Upcoming Financial Conference
Align Technology, Inc. (Align) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the...
Business Wire
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Zacks
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
Zacks
Here's How CVS Is Focusing on Aetna's Profitability Turnaround
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
Zacks
Here's How CVS' Improving Balance Sheet Supports Deleveraging
CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
Zacks
Quentin Blackford to Join Align Technology Board of Directors
Align Technology, Inc. (Align) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its...
Business Wire
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
Zacks
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
ALGN's record Clear Aligner growth and global adoption support the bull case, but demand softness and scanner pricing pressure keep investors cautious.
Zacks

Advertisement|Remove ads.